The China Eye Health Supplements Market faces structural challenges, primarily stemming from the regulatory environment and issues of consumer trust. The sector is highly regulated under China's Food Safety Law, with the State Administration for Market Regulation (SAMR, formerly CFDA) controlling health food registration and filing.

Regulatory Challenges include stringent approval processes. Products using ingredients outside the approved raw material dictionary require a complex and time-consuming registration process, which often includes submitting clinical trial data. This can slow the introduction of novel formulations. A critical Market Challenge is the erosion of consumer trust due to the historical presence of counterfeit or adulterated products, especially in emerging markets. Brands must focus on transparent sourcing, Good Manufacturing Practice (GMP) compliance, and clear labeling to reassure consumers, who often prefer trusted overseas brands due to perceived higher quality standards.

For details on the official compliance process and market entry barriers, consult the full industry report: China Eye Health Supplements Market.